Search results for: Value-Based Pricing
Filter search results
What is the impact of Uniform Pricing, Indication-Based Pricing (IBP) and alternative commercial arrangements for new pharmaceuticals in the UK NHS?
19 November 2024
…Pricing: Efficient Prices for Drugs in a Global Context: VALUE-BASED DIFFERENTIAL PRICING. Health Economics, 24(3), pp.294–301. Danzon, P.M., 2018. Affordability Challenges to Value-Based Pricing: Mass Diseases, Orphan Diseases, and Cures. Value in…
Delivering the Triple Win: A Value-Based Approach to Pricing
20 April 2023
…holistic definition of value Recognise qualitative evidence of value through deliberative processes To improve the implementation of value-based pricing, we recommend that healthcare system stakeholders: Fully embrace a value-based approach…
OHE’s submission to Belgium’s Committee on Health and Equal Opportunities argues value-based pricing delivers a ‘triple-win’
18 December 2024
…of medicines or pharmaceutical specialities to be based on transparent and objective criteria. Professor Cookson’s response proposes a value-based approach to pricing, which would allow: • Healthcare systems to appropriately reward…
Is Rate Of Return Pricing A Useful Approach When Value-Based Pricing Is Not Appropriate?
22 March 2019
…for RoR pricing in situations where the value-based price is considered to be inappropriate. The RoR price could be higher or lower than the value-based price, depending on the particular…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…by use of value-based assessment of health and health-related outcomes and by value-based pricing. Additional incentives may be needed for ultra-orphan drugs in oncology and other diseases. Effective management of…
A Market-based International Reference Price Index: Solution or Contradiction?
13 September 2019
…presence of an established value-based pricing framework. Formal value assessment is used to inform price setting in the Netherlands and Denmark, whilst IRP (which includes six countries: Germany, UK, Denmark,…
Update: Value-Based Pricing in the UK
11 January 2011
Value-based pricing for new medicines, proposed as part of UK health care reform, would create a QALY-plus approach for drugs approved starting 1 January 2014. For new drugs, this would…
Spotlight on OHE: Value Based Pricing and New Technologies
31 December 2012
…in incorporating WSB’s into VBP. A November workshop, “QALY Weightings For Value-Based Pricing: Technical Workshop”, focused on evidence relating to society’s differential valuation of health gains based on the particular…